Newmont Corporation's Trading Volume Drops 33.17% to $443 Million, Ranked Sixth in Daily Decline

Generated by AI AgentAinvest Volume Radar
Thursday, May 22, 2025 8:00 pm ET1min read

On May 22, 2025,

(NEM) saw a trading volume of $443 million, marking a 33.17% decrease from the previous day. The stock price of rose by 0.02%, marking its sixth consecutive day of gains, with a total increase of 8.20% over the past six days.

Newmont Corporation is set to trade ex-dividend in the next four days, with the ex-dividend date being one business day before the record date. This means that shareholders who purchase Newmont's shares on or after May 27 will not be eligible to receive the dividend, which is scheduled to be paid on June 20. The next dividend payment will be $0.25 per share, following last year's total payout of $1.00 to shareholders. Based on the current share price of $52.64,

stock has a trailing yield of around 1.9%.

Newmont's dividend payout is covered by both profits and cash flow, indicating sustainability. The company paid out just 23% of its profit and 27% of its free cash flow as dividends, leaving ample margin for unexpected circumstances. This conservative approach suggests a greater margin of safety before the dividend gets cut.

Newmont's earnings per share have grown at an annual rate of 2.8% over the past five years, and the company has delivered an average dividend growth of 26% per year over the past decade. This combination of earnings growth and dividend increases suggests that Newmont is committed to rewarding shareholders while maintaining a sustainable dividend policy.

Newmont is strategically positioned in the gold and copper markets, with high operating margins, record cash flow, and a robust financial structure. The company's long-term estimated earnings growth is 14.2%, and its expected earnings growth rate for the current year is 12.6%. This strong financial performance, coupled with a conservative dividend policy, makes Newmont a promising investment for long-term holders.

Comments



Add a public comment...
No comments

No comments yet